Shavadia, Jay S.
Alemayehu, Wendimagegn
deFilippi, Christopher
Westerhout, Cynthia M.
Tromp, Jasper
Granger, Christopher B.
Armstrong, Paul W. http://orcid.org/0000-0002-0460-3445
van Diepen, Sean
Funding for this research was provided by:
Duke Clinical Research Institute
Canadian VIGOUR Centre
Article History
Accepted: 3 October 2021
First Online: 27 October 2021
Declarations
:
: Dr. deFilippi received grant support from Roche Diagnostics, Siemens Heathineers and has served as a consultant for Roche Diagnostics, Siemens Heathineers, Ortho Clinical, Abbott Diagnostics, Fiji Rebio, Metanomics, Quidel, UpToDate, and WebMD. Dr. Granger received grant support and consulting fees from Boehringer Ingelheim, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Janssen Pharmaceutica, Pfizer, GlaxoSmithKline, and Sanofi, consulting fees and lecture fees from Boston Scientific, grant support from Merck, and consulting fees from AstraZeneca, Armetheon, Eli Lilly, Gilead, Hoffmann-La Roche, Medtronic, Takeda, and the Medicine Company. Dr. Povsic has received grants from Baxter Healthcare, Caladrius Biosciences, Capricor, CSL Behring, and Janssen Pharmaceuticals; and personal fees from Eli Lilly, NovoNordisk, and Pluristem. Dr. Armstrong has served as a consultant for Bayer and Merck, and received research grants from CSL, Boehringer Ingelheim, Bayer, and Merck. All other authors have no disclosures.
: The study was approved by all enrolling hospital research ethics boards and conforms with the Declaration of Helsinki.
: All patients provided informed consent.